Name: ACE-031 1mg
Brand: Capital Peptides
Price: 61 AUD
Availability: InStock

ACE-031

Janoshik-tested · 10 vials per kit

ACE-031 is a soluble activin receptor type IIB (ActRIIB) fusion protein studied in preclinical research as a myostatin and activin pathway inhibitor. Research has examined its potential to promote skeletal muscle growth and inhibit muscle-wasting signalling, with studies exploring applications in muscular dystrophy and disuse atrophy models.

Research applications

Myostatin inhibitor

Delivery & pricing

Choose pack size

$61

AUD · 1 vial

View COAs

≥98%

Purity

Lyophilised

Format

2–3 wks

Arrival

Don't want to wait 3 weeks?

Check local stock — weekday same/next-day delivery available.

View local →

Need to work out your dose?

Use our reconstitution calculator — syringe units in seconds.

Calculator →

Research Use Only — Disclaimer

This product is intended solely as a research chemical for laboratory and scientific study purposes only. It is not approved by the TGA or any regulatory body for human or animal consumption, therapeutic use, or clinical application. The information provided on this website is for educational purposes only. Handling must be limited to suitably qualified professionals operating within applicable laws and regulations. This product is not classified as a drug, food, cosmetic, or medicinal product and must not be used or labelled as such. By purchasing, you confirm you are a qualified research professional and accept full responsibility for compliance with all relevant laws in your jurisdiction.